HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy

Barbara Weiser, Sean Philpott, Thomas Klimkait, Harold Burger, Christina Kitchen, Philippe Bürgisser, Meri Gorgievski, Luc Perrin, Jean Claude Piffaretti, Bruno Ledergerber, C. Aebi, M. Battegay, E. Bernasconi, J. Böni, H. Bucher, Ph Bürgisser, A. Calmy, S. Cattacin, M. Cavassini, J. CheseauxR. Dubs, M. Egger, L. Elzi, P. Erb, M. Fischer, M. Flepp, A. Fontana, P. Francioli, H. Furrer, A. Gayet-Ageron, S. Gerber, M. Gorgievski, C. Grawe, H. Günthard, T. Gyr, H. Hirsch, B. Hirschel, I. Hösli, Ch Kahlert, L. Kaiser, U. Karrer, O. Keiser, C. Kind, Th Klimkait, B. Ledergerber, G. Martinetti, B. Martinez De Tejada, N. Müller, D. Nadal, M. Opravil, F. Paccaud, G. Pantaleo, L. Perrin, S. Regenass, M. Rickenbach, C. Rudin, P. Schmid, D. Schultze, J. Schüpbach, R. Speck, P. Taffé, P. Tarr, A. Telenti, A. Trkola, Y. Vallet, P. Vernazza, A. Wechsler, R. Weber, D. Wunder, C. Wyler, S. Yerly

Research output: Contribution to journalArticle

56 Scopus citations

Fingerprint Dive into the research topics of 'HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences